SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Niles JL. Antineutrophil cytoplasmic antibodies in the classification of vasculitis. Annu Rev Med 1996; 47: 30313.
  • 2
    Gross WL. Antineutrophil cytoplasmic autoantibody testing in vasculitides. Rheum Dis Clin North Am 1995; 21: 9871011.
  • 3
    Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol 1997; 8: 31422.
  • 4
    Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Akesson A. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 1990; 81: 3803.
  • 5
    Nassberger L, Johansson AC, Bjorck S, Sjoholm AG. Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment. J Intern Med 1991; 229: 2615.
  • 6
    Almroth G, Enestrom S, Hed J, Samuelsson I, Sjostrom P. Autoantibodies to leucocyte antigens in hydralazine-associated nephritis. J Intern Med 1992; 231: 3742.
  • 7
    Short AK, Lockwood CM. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis. QJM 1995; 88: 77583.
  • 8
    Cambridge G, Wallace H, Bernstein RM, Leaker B. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol 1994; 33: 10914.
  • 9
    Choi HK, Merkel PA, Tervaert JWC, Black RM, McCluskey RT, Niles JL. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis. Arthritis Rheum 1999; 42: 3848.
  • 10
    Dolman KM, Gans RO, Vervaat TJ, Zevenbergen G, Maingay D, Nikkels RE, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342: 6512.
  • 11
    Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 1994; 124: 9868.
  • 12
    Tanemoto M, Miyakawa H, Hanai J, Yago M, Kitaoka M, Uchida S. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases. Am J Kidney Dis 1995; 26: 77480.
  • 13
    D'Cruz D, Chesser AM, Lightowler C, Comer M, Hurst MJ, Baker LR, et al. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol 1995; 34: 10901.
  • 14
    Yuasa S, Hashimoto M, Yura T, Sumikura T, Takahashi N, Shoji T, et al. Antineutrophil cytoplasmic antibodies (ANCA)-associated crescentic glomerulonephritis and propylthiouracil therapy. Nephron 1996; 73: 7013.
  • 15
    Kitahara T, Hiromura K, Maezawa A, Ono K, Narabara N, Yano S, et al. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature. Clin Nephrol 1997; 47: 33640.
  • 16
    Locke IC, Worrall JG, Leaker B, Black CM, Cambridge G. Autoantibodies to myeloperoxidase in systemic sclerosis. J Rheumatol 1997; 24: 869.
  • 17
    Mathieson PW, Peat DS, Short A, Watts RA. Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with penicillamine. Nephrol Dial Transplant 1996; 11: 8636.
  • 18
    Gaskin G, Thompson EM, Pusey CD. Goodpasture-like syndrome associated with anti-myeloperoxidase antibodies following penicillamine treatment. Nephrol Dial Transplant 1995; 10: 19258.
  • 19
    Elkayam O, Yaron M, Caspi D. Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA. Ann Rheum Dis 1996; 55: 76971.
  • 20
    Kawachi Y, Nukaga H, Hoshino M, Iwata M, Otsuka F. ANCA-associated vasculitis and lupus-like syndrome caused by methimazole. Clin Exp Dermatol 1995; 20: 3457.
  • 21
    Salerno SM, Ormseth EJ, Roth BJ, Meyer CA, Christensen ED, Dillard TA. Sulfasalazine pulmonary toxicity in ulcerative colitis mimicking clinical features of Wegener's granulomatosis. Chest 1996; 110: 5569.
  • 22
    Jaunkalns R, Shear NH, Sokoluk B, Gardner D, Claas F, Uetrecht JP. Antimyeloperoxidase antibodies and adverse reactions to clozapine. Lancet 1992; 339: 16112.
  • 23
    Parry RG, Gordon P, Mason JC, Marley NJ. Phenytoin-associated vasculitis and ANCA positivity: a case report. Nephrol Dial Transplant 1996; 11: 3579.
  • 24
    Pillinger M, Staud R. Wegener's granulomatosis in a patient receiving propylthiouracil for Graves' disease. Semin Arthritis Rheum 1998; 28: 1249.
  • 25
    Wallace D. Dubois' lupus erythematosus. 5th ed. Baltimore: Williams & Wilkins; 1996.
  • 26
    Niles JL, Pan GL, Collins AB, Shannon T, Skates S, Fienberg R, et al. Antigen-specific radioimmunoassays for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis. J Am Soc Nephrol 1991; 2: 2736.
  • 27
    Fienberg R, Mark EJ, Goodman M, McCluskey RT, Niles JL. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis. Hum Pathol 1993; 24: 1608.
  • 28
    Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997; 126: 86673.
  • 29
    Caulier M, Dromer C, Andrieu V, Le Guennec P, Fournie B. Sulfasalazine induced lupus in rheumatoid arthritis. J Rheumatol 1994; 21: 7501.
  • 30
    Choi HK, Merkel PA, Niles JL. ANCA-positive vasculitis associated with allopurinol therapy. Clin Exp Rheumatol 1998; 16: 7434.
  • 31
    Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol 1997; 8: 37685.
  • 32
    Honda H, Shibata T, Hara H, Ban Y, Sugisaki T. MPO-ANCA in patients with Graves' disease, strong association with propylthiouracil therapy [abstract]. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 280.
  • 33
    Cohen Tervaert JW, Tel W, de Vries O, Links CA, Stegeman CA. The occurrence of anti-neutrophil cytoplasmic antibodies with specificity for proteinase 3, myeloperoxidase, and/or elastase during treatment with antithyroid drugs [abstract]. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 280.
  • 34
    Bygren P, Rasmussen N, Isaksson B, Wieslander J. Anti-neutrophil cytoplasm antibodies, anti-GBM antibodies and anti-dsDNA antibodies in glomerulonephritis. Eur J Clin Invest 1992; 22: 78392.
  • 35
    Cohen Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, et al. Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 1990; 37: 799806.
  • 36
    Velosa JA, Homburger HA, Holley KE. Prospective study of anti-neutrophil cytoplasmic autoantibody tests in the diagnosis of idiopathic necrotizing-crescentic glomerulonephritis and renal vasculitis. Mayo Clinic Proc 1993; 68: 5615.
  • 37
    Bosch X, Llena J, Collado A, Font J, Mirapeix E, Ingelmo M, et al. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis. J Rheumatol 1995; 22: 203845.
  • 38
    Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis: EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998; 53: 74353.
  • 39
    Klippel JH, editor. Primer on the rheumatic diseases. 11th ed. Atlanta: Arthritis Foundation; 1997.
  • 40
    Cameron HA, Ramsay LE. The lupus syndrome induced by hydralazine: a common complication with low dose treatment. BMJ 1984; 289: 4102.
  • 41
    Amrhein JA, Kenny FM, Ross D. Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J Pediatr 1970; 76: 5463.
  • 42
    Waldhauser L, Uetrecht J. Antibodies to myeloperoxidase in propylthiouracil-induced autoimmune disease in the cat. Toxicology 1996; 114: 15562.
  • 43
    Arellano F, Sacristan JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 1993; 27: 33743.
  • 44
    Veale DJ, Ho M, Morley KD. Sulphasalazine-induced lupus in psoriatic arthritis. Br J Rheumatol 1995; 34: 3834.
  • 45
    Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994; 266: 8103.